Small molecules for treating breast cancer
US9359299B2 · kind B2 · utility
0Cited by
1References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 4, 2012 |
| Grant date | Jun 7, 2016 |
| Priority date | — |
| Expiry date | Apr 4, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Small molecule inhibitors of XBP1 splicing by IRE1 are provided, as well as methods for their use in treating or preventing cancer (e.g., endocrine resistant breast cancer), diabetes, and obesity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.